KKR

KKR & Co. Inc.
NYSEFINANCIAL SERVICESASSET MANAGEMENT

Key Statistics

Market Cap
$88.71B
P/E Ratio
32.69
EPS
$2.91
Beta
1.79
52W High
$152.85
52W Low
$82.51
50-Day MA
$96.48
200-Day MA
$110.23
Dividend Yield
0.78%
Profit Margin
11.70%
Forward P/E
15.41
PEG Ratio
0.50

About KKR & Co. Inc.

KKR & Co. Inc. is a preeminent global investment firm founded in 1976, specializing in private equity, credit, and real asset investments. With a keen focus on identifying complex market opportunities, KKR leverages its extensive industry expertise and global network to drive sustainable long-term value for its portfolio companies. The firm is a leader in sustainable investing, integrating robust environmental, social, and governance (ESG) criteria into its investment strategy to promote responsible market growth alongside financial performance. KKR's commitment to innovation and operational excellence further cements its position as a vital contributor to the financial landscape worldwide.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$25.35B
Gross Profit (TTM)$14.08B
EBITDA
Operating Margin11.00%
Return on Equity7.66%
Return on Assets1.46%
Revenue/Share (TTM)$28.45
Book Value$31.43
Price-to-Book3.01
Price-to-Sales (TTM)3.50
EV/Revenue0.479
EV/EBITDA0.99
Quarterly Earnings Growth (YoY)-2.20%
Quarterly Revenue Growth (YoY)-6.60%
Shares Outstanding$897.87M
Float$690.35M
% Insiders23.05%
% Institutions62.06%

Historical Volatility

HV 10-Day
32.45%
HV 20-Day
30.23%
HV 30-Day
33.26%
HV 60-Day
35.77%
HV Rank
45.2%

Volatility is currently contracting

Analyst Ratings

Consensus ($125.29 target)
6
Strong Buy
12
Buy
3
Hold

Latest News

KKR Launches Allyntra, an Engineered Solutions Platform for Medical Technology and Precision Industries

NEW YORK--(BUSINESS WIRE)--KKR today announced the launch of Allyntra (“Allyntra” or the “Company”), a newly formed precision-engineered solutions platform serving medical technology and other precision end markets. Allyntra builds on KKR's existing investment in Precipart through its Health Care Strategic Growth Fund II, with Precipart serving as one of the foundational businesses within the platform. KKR is committing meaningful additional capital to support Allyntra's growth by acquiring and.

Business Wire7/9/2026Neutral
Arctos Announces Final Close of Arctos Keystone Partners Fund I at $6.2 Billion

NEW YORK--(BUSINESS WIRE)--Arctos, a business of KKR, today announced the final close of Arctos Keystone Partners Fund I (“Keystone Fund I” or the “Fund”), its inaugural fund dedicated to providing bespoke growth capital and financing to leading alternative asset managers. Keystone Fund I, and its affiliated vehicles, closed with $6.2 billion in capital commitments from a diverse group of global investors, including some of the world's leading pension funds, retirement systems, endowments, insu.

Business Wire7/7/2026Neutral
KKR Could Be The Biggest Bargain In Private Equity (Rating Upgrade)

KKR & Co. Inc. earns a Strong Buy rating, driven by aggressive capital deployment in infrastructure and undervalued secular growth areas. Recent $4.2B acquisition of EDF's North American operations accelerates KKR's exposure to renewables, data centers, and electrification megatrends. KKR's model emphasizes high-margin, performance-fee-driven growth, with 10–25% long-term AUM and fee-related earnings targets.

Seeking Alpha7/2/2026Positive
KKR & Co. Inc. to Announce Second Quarter 2026 Results

NEW YORK--(BUSINESS WIRE)--KKR & Co. Inc. (NYSE: KKR) announced today that it plans to release its financial results for the second quarter 2026 on Thursday, July 30, 2026, before the opening of trading on the New York Stock Exchange.A conference call to discuss KKR's financial results will be held on Thursday, July 30, 2026 at 9:00 a.m. ET. The conference call may be accessed by dialing (877) 407-0312 (U.S. callers) or +1 (201) 389-0899 (non-U.S. callers); a pass code is not required. Addit.

Business Wire7/1/2026Neutral

More FINANCIAL SERVICES Stocks

Data last updated: 7/9/2026